A coronavirus vaccine has not yet been approved but there are two frontrunners in late-stage clinical trials.
Vaccine trial chief investigator Andrew Pollard told the Science and Technology Committee he is “optimistic” the University of Oxford trial could present late-stage results, possibly revealing whether it works, before the end of the year.
Vaccine trial chief investigator Andrew Pollard told the Science and Technology Committee he is “optimistic” the University of Oxford trial could present late-stage results, possibly revealing whether it works, before the end of the year.